Non-invasive decision support for NSCLC treatment using PET/CT radiomics
EGFR mutations are common in non-small cell lung cancer and patients with these mutations are treated with tyrosine kinase inhibitors. Here, the authors show that EGFR mutation status can be predicted from 18F-FDG-PET/CT images, which may enable the stratification of patients for treatment.
Bibliographic Details
| Main Authors: |
Wei Mu,
Lei Jiang,
JianYuan Zhang,
Yu Shi,
Jhanelle E. Gray,
Ilke Tunali,
Chao Gao,
Yingying Sun,
Jie Tian,
Xinming Zhao,
Xilin Sun,
Robert J. Gillies,
Matthew B. Schabath |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Portfolio
2020-10-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-020-19116-x
|
|---|